Dr. Simi Paknikar's Profile
Dr. Simi Paknikar is an MD in Pharmacology with professional experience of over a decade, that includes medical writing, teaching and conducting quality audits for medical services companies. Dr Paknikar is passionate about educating consumers about health and keeps abreast of the latest medical research. She contributes by editing and reviewing articles as well as writing on various health topics.
Written / Edited / Medically Reviewed
The World Pancreatic Cancer Day is being celebrated on November 16, 2017, aims to early diagnosis and improve outcomes for the patient.
Two phase 3 clinical trials indicate better efficacy and safety of ozanimod for the treatment of relapsing multiple sclerosis.
Somatic symptom disorder is said to occur when a person’s focus, feelings and behavior related to physical symptoms is excessive and affects normal functioning.
Non-small cell lung cancers show genetic changes during treatment with targeted therapy; combination targeted therapies or regular monitoring of genetic changes during treatment may be required.
Acalabrutinib,a Bruton tyrosine kinase(BTK) inhibitor, has received the ‘Breakthrough Therapy Designation’from the US FDA for the treatment of relapsed or non-responding cases of mantle cell lymphoma.